Company / FCF Margin
TREACE MEDICAL CONCEPTS, INC. FCF Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-24.6%
FY2025
5-year range
-32.1% / -9.7%
FY2021-FY2025
Trend
+23.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2025 after 2 years of decline, reaching -24.6%.
Based on SEC 10-K filings.
-24.6% in FY2025 with a 3-year CAGR of -14.9%.
Declined from -21.1% to -24.6% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -14.9pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 23.3% year-over-year.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 1.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -24.6% | +23.3% |
| FY2024 | -32.1% | -52.2% |
| FY2023 | -21.1% | -117.2% |
| FY2022 | -9.7% | +57.0% |
| FY2021 | -22.5% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026